<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph-family" /><meta name="keywords" content="Interferon: beta; Multiple sclerosis: interferon beta" /><meta name="IX" content="Interferon: beta; Multiple sclerosis: interferon beta" /><title>Interferon beta: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="37083.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="37083.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=37083.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2075.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="4777.htm">8.2 Drugs affecting the immune response</a> &gt; <a href="4789.htm">8.2.4 Other immunomodulating drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="88648.htm" title="Previous: PEGINTERFERON ALFA">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="37090.htm" title="Next: INTERFERON BETA">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a301061.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon Alfa (Antiviral)</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antivirals 8:18 &gt; Interferons 8:18.20</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a390006.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon Alfa (Antineoplastic)</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a393040.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon Beta</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Biologic Response Modifiers 92:20</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22interferon%22%22multiple+sclerosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Stockley's Interaction Alerts (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/11419-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Interferon alfa</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: I &gt; Interactions of Interferon alfa</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/11420-l.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Interferon beta</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: I &gt; Interactions of Interferon beta</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/1683-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Interferon gamma</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: I &gt; Interactions of Interferon gamma</p></div></li></ul><ul><li><h3>British National Formulary (22)</h3></li><li><a href="217714.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.3.1 Chronic hepatitis B</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.3 Viral hepatitis</p></div></li><li><a href="217719.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.3.2 Chronic hepatitis C</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.3 Viral hepatitis</p></div></li><li><a href="37082.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon alfa</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.4 Other immunomodulating drugs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22interferon%22%22multiple+sclerosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (22)</a></li></ul><ul><li><h3>BNF for Children (9)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/129085.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.3 Viral hepatitis</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/37082.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon alfa</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.4 Other immunomodulating drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/10864.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">INTERFERON ALFA</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.4 Other immunomodulating drugs &gt; Interferon alfa</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22interferon%22%22multiple+sclerosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (9)</a></li></ul><ul><li><h3>Dietary Supplements (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c35.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fish oils</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; F</p></div></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c42.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ginkgo biloba</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c98.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vitamin B12</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; V</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22interferon%22%22multiple+sclerosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a597012.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon Alfa-2b</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; I</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0009s0079.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon α 2b</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; I</p></div></li></ul><ul><li><h3>Kucers' the Use of Antibiotics (6)</h3></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/interferon_alfa_description.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Description</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Agents Active Against Hepatitis Viruses &gt; 253 Interferon Alfa</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/interferon_alfa_antimicrobial_activity.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antimicrobial activity</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Agents Active Against Hepatitis Viruses &gt; 253 Interferon Alfa</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/interferon_alfa_mechanism_of_drug_action.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mechanism of drug action</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Agents Active Against Hepatitis Viruses &gt; 253 Interferon Alfa</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22interferon%22%22multiple+sclerosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (5)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/11419-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon Alfa</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antivirals &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/11420-l.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon Beta</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antivirals &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1683-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon Gamma</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antivirals &gt; Drug Monographs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22interferon%22%22multiple+sclerosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>The Merck Index (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04989.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; I &gt; IN</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04990.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon-α</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; I &gt; IN</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04991.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon-β</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; I &gt; IN</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22interferon%22%22multiple+sclerosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Stockley's Drug Interactions (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E6E3E0R0D118.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Interferon alfa</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; I</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E4E3E0R0D118.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Interferon beta</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; I</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E4E3E0R0D3468.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Interferon gamma</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; I</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_37083">Interferon beta</h1><?highlighter on?><div id="pC" class="jN"><div><p><b><span>Interferon beta</span></b> is licensed for
use in patients with <i>relapsing, remitting multiple sclerosis</i> (characterised by at least two attacks of neurological dysfunction
over the previous 2 or 3 years, followed by complete or incomplete
recovery) who are able to walk unaided. Not all patients respond and
a deterioration in the bouts has been observed in some. It is also
licensed for use in patients with a single demyelinating event with
an active inflammatory process, if it is severe enough to require
treatment with an intravenous corticosteroid, and they are at high
risk of developing multiple sclerosis. Interferon beta-1b is also
licensed for use in patients with <i>secondary progressive multiple
sclerosis</i> but its role in this condition has not been confirmed. </p><div id="_204314"><div class="cAZ"><h2>Cautions</h2> <p class="cAX"><span id="_37083.2">Caution is advised in those with severe
hepatic or renal impairment or a history of cardiac disorders, depressive
disorders (avoid in severe depression or in those with suicidal ideation), seizures, or severe myelosupression.
Patients should be monitored for signs of hepatic injury.</span> </p></div></div><div id="_211863"><div class="cAZ"><h2>Contra-indications</h2> <p class="cAX">Avoid treatment with interferon
beta in patients with severe depressive illness or those with decompensated liver disease.</p></div></div><div class="cAZ"><h2>Side-effects</h2> <p class="cAX">Side-effects reported most frequently
include irritation at injection site (including inflammation, hypersensitivity,
necrosis) and influenza-like symptoms (fever, chills, myalgia, or
malaise) but these decrease over time; nausea and vomiting occur occasionally.
Other side-effects include hypersensitivity reactions (including anaphylaxis
and urticaria), blood disorders, menstrual disorders, mood and personality
changes, suicide attempts, confusion and convulsions; alopecia, hepatitis,
and thyroid dysfunction have been reported rarely with interferon
beta-1b. </p></div><div id="_120001"><div class="cN"><h2 class="cBR">NICE guidance</h2><h3 class="cBP">Interferon beta and glatiramer for multiple sclerosis
(January 2002)</h3><p>Interferon beta and glatiramer acetate are <b>not</b> recommended for the treatment of multiple sclerosis in the NHS in
England and Wales.</p><p>Patients who are currently receiving interferon beta or glatiramer
acetate for multiple sclerosis, whether as routine therapy or as part
of a clinical trial, should have the option to continue treatment
until they and their consultant consider it appropriate to stop, having
regard to the established criteria for withdrawal from treatment.</p></div></div><div id="_120002"><div class="cN"><h3 class="cBP">Provision of disease-modifying therapies for multiple
sclerosis</h3><p>The Department of Health, the National Assembly for Wales, the
Scottish Executive, the Northern Ireland Department of Health, Social
Services &amp; Public Safety, and the manufacturers have reached agreement
on a risk-sharing scheme for the NHS supply of interferon beta and
glatiramer acetate for multiple sclerosis. Health Service Circular
(<a href="http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Healthservicecirculars/DH_4004332" title="external link">HSC 2002/004</a>) explains how patients
can participate in the scheme. It is available on the Department of
Health website (<a href="http://www.doh.gov.uk/publications/coinh.html" title="external link">www.dh.gov.uk</a>).</p></div></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_37090"><a href="37090.htm" title="INTERFERON BETA">INTERFERON BETA</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="88648.htm">Previous: PEGINTERFERON ALFA</a> | <a class="top" href="37083.htm#">Top</a> | <a accesskey="]" href="37090.htm">Next: INTERFERON BETA</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>